Browse articles on EyeWorld.org from the Cornea section. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Clara Chan, MD, introduces the Cornea section of the issue.
Corneal imaging for IOL planning is vital, but what instruments to use and what the measurements from these different instruments inform varies. EyeWorld spoke with two physicians to get their thoughts on corneal imaging as part of the preop planning process.
Aqueous tear deficient dry eye and evaporative dry eye—distinguishing between the two, knowing when both are at play, and treatment options are of growing importance as more patients are identified with some form of dry eye and as certain refractive procedures depend on a healthy ocular surface.
When talking about infectious keratitis in the U.S., this usually refers to bacterial keratitis, which has a higher incidence than fungal keratitis. However, there are reportedly 30,000–40,000 new cases of fungal keratitis annually, so it’s still a significant number.
More than 2 years after being blinded in a “freak fireworks accident,” European football player Omar Elabdellaoui received a vision-restoring corneal transplant performed by Edward Holland, MD.
Cornea Editor Clara Chan, MD, talks about her experience incorporating new techniques and technologies into her practice and previews the articles in the section.
Scleral lenses are an option that many physicians use to help patients suffering from more severe and advanced cases of dry eye disease. Two ophthalmologists discussed the options and how these fit into the treatment of dry eye.
New diagnostic techniques are often developed when a need in the clinic or OR arises. That is what led one physician to develop the corneal sweep test and a new diagnostic tool to identify recurrent corneal erosion.
Restasis (cyclosporine ophthalmic emulsion) was developed by Allergan and approved by the U.S. FDA in 2003. Now, after nearly 2 decades since its approval as a brand name drug indicated for symptoms of dry eye, a generic version of Restasis has been approved. It was a “long time coming,” according to Henry Perry, MD.
EyeWorld Cornea Editor Clara Chan, MD, discusses “one of her most dramatic cases” involving ocular complications associated with rosacea, previews the content in the Cornea section of this issue, and shares excitement for the ASCRS Annual Meeting.